IMPACT OF MIRABEGRON TREATMENT AND SYMPTOM SEVERITY ON WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH OVERACTIVE BLADDER

被引：1
|
作者：
De, G. [1 ]
Yang, H. [2 ]
Runken, M. C. [3 ]
Yan, Y. [1 ]
Kelkar, S. [1 ]
Bui, C. N. [3 ]
Xie, J. [1 ]
Wu, E. Q. [2 ]
机构：
[1] Anal Grp Inc, New York, NY USA
[2] Anal Grp Inc, Boston, MA USA
[3] Astellas Pharma US Inc, Northbrook, IL USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.923
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A183 / A184
页数：2
相关论文
共 50 条
  • [1] Impact of Overactive Bladder on Work Productivity
    Coyne, Karin S.
    Sexton, Chris C.
    Thompson, Christine L.
    Clemens, J. Quentin
    Chen, Chieh I.
    Bavendam, Tamara
    Dmochowski, Roger
    UROLOGY, 2012, 80 (01) : 97 - 103
  • [2] MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
    Gras, J.
    DRUGS OF TODAY, 2012, 48 (01) : 25 - 32
  • [3] Mirabegron in the treatment of overactive bladder
    Maggiore, Umberto Leone Roberti
    Cardozo, Linda
    Ferrero, Simone
    Sileo, Filomena
    Cola, Alice
    Torella, Marco
    Colacurci, Nicola
    Candiani, Massimo
    Salvatore, Stefano
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (06) : 873 - 887
  • [4] Impact of disease severity on work productivity and activity impairment in Japanese patients with psoriasis
    Saeki, H.
    Ito, T.
    Fukuchi, O.
    Umezawa, Y.
    Katayama, H.
    Tanito, K.
    Igarashi, A.
    Etoh, T.
    Hasegawa, T.
    Nakagawa, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 60 - 60
  • [5] Impact of disease severity on work productivity and activity impairment in Japanese patients with psoriasis
    Hayashi, Mitsuha
    Saeki, Hidehisa
    Ito, Toshihiro
    Fukuchi, Osamu
    Umezawa, Yoshinori
    Katayama, Hiroyasu
    Tanito, Katsumi
    Igarashi, Atsuyuki
    Etoh, Takafumi
    Hasegawa, Tomonori
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2013, 72 (02) : 188 - 191
  • [6] Value of Mirabegron in the Treatment of overactive Bladder
    Schneider, M. H.
    Struck, J. P.
    UROLOGE, 2019, 58 (04): : 432 - 433
  • [7] Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder
    Michel, MC
    de la Rosette, JJMCH
    Piro, M
    Schneider, T
    EUROPEAN UROLOGY, 2005, 48 (01) : 110 - 115
  • [8] Economic Impact Associated with Patients with Overactive Bladder on Drug Treatment with Mirabegron or Antimuscarinics in Spain
    Nunez, Aurora Ortiz
    de Almeida, Rodrigo Martins
    Arrom, Laura Mateu
    Terres, Carlos Rubio
    Rodriguez, Dario Rubio
    Blazquez, Ana Maria Mora
    ARCHIVOS ESPANOLES DE UROLOGIA, 2023, 76 (01): : 98 - 106
  • [9] Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis
    Yano, Chizuko
    Saeki, Hidehisa
    Ishiji, Takaoki
    Ishiuji, Yozo
    Sato, Junko
    Tofuku, Yukari
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2013, 40 (09): : 736 - 739
  • [10] Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response
    Mehmet Gokhan Culha
    Recep Burak Degirmentepe
    Sait Ozbir
    Suleyman Sami Cakir
    Yukio Homma
    International Urogynecology Journal, 2019, 30 : 2121 - 2126
12345